胎盘内胎儿血管直径可能有助于预测胎盘植入谱系疾病高危孕妇的胎盘侵袭性
本前瞻性试验纳入160例疑似胎盘植入谱系疾病(PAS)孕妇,由两名泌尿生殖放射科医师评估胎盘内胎儿血管(IFV)的存在及最大直径。结果显示,IFV可见与PAS(相对危险度2.4)及胎盘穿透(相对危险度10)相关;IFV直径≥2mm与PAS相关(AUC 0.81),≥3mm与胎盘穿透及围产期并发症(包括大出血)相关(AUC 0.81、0.80)。将IFV与其他MRI描述符联合评估可提高MRI预测PAS的能力(AUC 0.94 vs 0.89,P=0.009)。
要点
- IFV可见时PAS相对危险度为2.4(95%CI 1.6,3.4;P<.001),胎盘穿透相对危险度为10(95%CI 1.5,70.4;P<.001)。
- IFV直径≥2mm与PAS相关(AUC 0.81;95%CI 0.67,0.95;P=.04)。
- IFV直径≥3mm与胎盘穿透(AUC 0.81;95%CI 0.73,0.89;P<.001)及围产期并发症包括大出血(AUC 0.80;95%CI 0.71,0.89;P<.001)相关。
核心结论
- 将胎盘内胎儿血管评估与其他MRI描述符联合可提高MRI辅助预测PAS的能力(AUC 0.94 vs 0.89;P=.009)。
- 血管直径≥3mm可预测胎盘穿透和围产期并发症。
研究设计与样本
- 前瞻性试验的二次分析,2016年3月至2019年10月纳入160例疑似PAS孕妇,最终评估155例(平均年龄35岁±5,平均孕周32周±3)。
- 由两名经验丰富的泌尿生殖放射科医师评估IFV的存在及最大直径,以术中和组织病理学发现为参考标准。
关键影像表现/征象
- MRI检出IFV在PAS孕妇中为109/126(86%),在胎盘穿透孕妇中为67/68(98%)。
- IFV可见时PAS相对危险度为2.4(95%CI 1.6,3.4;P<.001),胎盘穿透相对危险度为10(95%CI 1.5,70.4;P<.001)。
诊断标准与关键数值
- IFV直径≥2mm与PAS相关(AUC 0.81;95%CI 0.67,0.95;P=.04)。
- IFV直径≥3mm与胎盘穿透相关(AUC 0.81;95%CI 0.73,0.89;P<.001)。
- IFV直径≥3mm与围产期并发症包括大出血相关(AUC 0.80;95%CI 0.71,0.89;P<.001)。
- IFV联合其他MRI描述符预测PAS的AUC为0.94,其他MRI描述符单独预测的AUC为0.89(P=.009)。
临床应用与阅片要点
- 阅片时可测量胎盘内胎儿血管最大直径,≥3mm提示胎盘穿透及围产期并发症风险。
- 将IFV评估与其他MRI描述符(如肌层变薄、胎盘内T2低信号带、子宫膨隆、浆膜面富血供、宫外胎盘蔓延征象)联合使用可提高预测PAS能力。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Prenatal identification of placenta accreta spectrum (PAS) disorder is essential for treatment planning. More objective means for predicting PAS and clinical outcome may be provided by MRI descriptors. Purpose To investigate the association of intraplacental fetal vessel (IFV) diameter at MRI with PAS and peripartum complications. Materials and Methods Between March 2016 and October 2019, 160 gravid women suspected of having PAS underwent placental MRI as part of a prospective trial. Secondary analysis was performed by two experienced genitourinary radiologists for presence and maximum diameter of IFVs. Relative risk ratios were computed to test the association of IFVs with presence and depth of PAS invasiveness. Receiver operating characteristic analysis was used to evaluate the ability of IFV diameter to help predict PAS, placenta percreta, and peripartum complications and for comparison of the area under the curve (AUC) versus that from other combined MRI predictors of PAS (eg, myometrial thinning, intraplacental T2-hypointense bands, uterine bulge, serosal hypervascularity, and signs of extrauterine placental spread). Intraoperative and histopathologic findings were the reference standard. Results A total of 155 women were evaluated (mean age, 35 years ± 5 [standard deviation]; mean gestational age, 32 weeks ± 3). PAS was diagnosed in 126 of 155 women (81%) (placental percreta in 68 of 126 [54%]). At delivery, 30 of 126 women (24%) experienced massive blood loss (>2000 mL). IFVs were detected at MRI in 109 of 126 women with PAS (86%) and in 67 of 68 women with placental percreta (98%). The relative risk ratio was 2.4 (95% CI: 1.6, 3.4; P < .001) for PAS and 10 (95% CI: 1.5, 70.4; P < .001) for placental percreta when IFVs were visible. IFVs of 2 mm or greater were associated with PAS (AUC, 0.81; 95% CI: 0.67, 0.95; P = .04). IVFs of 3 mm or greater were associated with placenta percreta (AUC, 0.81; 95% CI: 0.73, 0.89; P < .001) and with peripartum complications, including massive bleeding (AUC, 0.80; 95% CI: 0.71, 0.89; P < .001). Combining assessment of IFVs with other MRI descriptors improved the ability of MRI to predict PAS (AUC, 0.94 vs 0.89; P = .009). Conclusion Assessment of intraplacental fetal vessels with other MRI descriptors improved the ability of MRI to help predict PAS. Vessel diameter of 3 mm or greater was predictive of placenta percreta and peripartum complications. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Dighe in this issue.
引用
- Bourgioti C, Konstantinidou AE, Zafeiropoulou K, et al. Intraplacental Fetal Vessel Diameter May Help Predict for Placental Invasiveness in Pregnant Women at High Risk for Placenta Accreta Spectrum Disorders. Radiology. 2020. PMID: 33231529. doi:10.1148/radiol.2020200273
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。